![Helen Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Kim
Director/Board Member at
PELOTON THERAPEUTICS, INC.
Net worth: - $ as of 30/05/2026
Profile
Helen Susan Kim currently works at Peloton Therapeutics, Inc., as Director from 2017, Phylaxis Bioscience, as Director from 2024, ReCode Therapeutics, Inc., as Director from 2020, and various other companies.
Ms. Kim also formerly worked at Kosan Biosciences, Inc., as President & Chief Executive Officer from 2007 to 2008, TRF Pharma, Inc., as Chief Executive Officer & Director, Sunesis Pharmaceuticals, Inc., as Board Director from 2009 to 2011, and various other companies.
Ms. Kim received her undergraduate degree in 1985 from Northwestern University, Masters Business Admin degree in 1988 from The University of Chicago, and graduate degree from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PROTHENA CORP. PLC -.--% | 01/03/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
AKTIS ONCOLOGY, INC. -.--% | 07/01/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Helen Kim active positions
| Companies | Position | Start |
|---|---|---|
| PELOTON THERAPEUTICS, INC. | Director/Board Member | 31/10/2017 |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Director/Board Member | 31/03/2019 |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Director/Board Member | 29/02/2020 |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Director/Board Member | 30/11/2020 |
Protego Therapeutics, Inc. | Director/Board Member | 30/09/2021 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Private Equity Investor | 31/03/2019 |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 31/03/2019 |
Alterome Therapeutics, Inc.
 Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Director/Board Member | - |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Director/Board Member | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Helen Kim
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Helen Kim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
36
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 36 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
TRF Pharma, Inc.
 TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
ForSight VISION4, Inc.
 ForSight VISION4, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drug delivery therapies for treatment of retinal diseases | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity Biosystems, Inc.
 Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Develops and formulates orally delivered bio-therapeutic macromolecules | Health Technology |
Gordon & Betty Moore Foundation
 Gordon & Betty Moore Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a grantmaking organization | Commercial Services |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
WCCT Global, Inc.
 WCCT Global, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical contract research organization | Commercial Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Assembly Biosciences, Inc.
 Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Vida Ventures LLC
Vida Ventures LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Commercial Services |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Health Technology |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Health Technology |
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Health Technology |
InduPro, Inc.
 InduPro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies | Commercial Services |
Protego Therapeutics, Inc. |
- Stock Market
- Insiders
- Helen Kim
